Table 5.
Outcomes of COVID-19 patients
| Items | Total (N=417) | Disease severity | P value | |
|---|---|---|---|---|
|
| ||||
| Severe (n=81) | Non-severe (n=336) | |||
| Time to nucleic acid negative (days), median (IQR) | 15.0 (11.0-22.0) | 19.0 (13.0-28.0) | 14.0 (10.0-20.5) | <0.001 |
| Disease condition, No. (%) | ||||
| Cured | 3 (0.7) | 0 (0.0) | 3 (0.9) | 0.393 |
| Improved | 400 (95.9) | 70 (86.5) | 330 (98.2) | <0.001 |
| Aggravated | 11 (2.6) | 8 (9.9) | 3 (0.9) | <0.001 |
| Dead | 3 (0.7) | 3 (3.7) | 0 (0.0) | 0.007 |
Comparison was determined by Wilcoxon rank sum test, Chi-square test or Fisher’s exact test. COVID-19, coronavirus disease 2019; IQR, interquartile range.